Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1
2016-01-01 Smith, M; De Bono, J; Sternberg, C; Le Moulec, S; Oudard, S; De Giorgi, U; Krainer, M; Bergman, A; Hoelzer, W; De Wit, R; Bögemann, M; Saad, F; Cruciani, G; Thiery-Vuillemin, A; Feyerabend, S; Miller, K; Houédé, N; Hussain, S; Lam, E; Polikoff, J; Stenzl, A; Mainwaring, P; Ramies, D; Hessel, C; Weitzman, A; Fizazi, K.
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer
2016-01-01 Passardi, A; Scarpi, E; Cavanna, L; Dall'Agata, M; Tassinari, D; Leo, S; Bernardini, I; Gelsomino, F; Tamberi, S; Brandes, Aa; Tenti, E; Vespignani, R; Frassineti, Gl; Amadori, D; De Giorgi, U
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey
2016-01-01 Diminutto, A; Basso, U; Maruzzo, M; Morelli, F; De Giorgi, U; Perin, A; Fraccon, Ap; Lo Re, G; Rizzi, A; Sava, T; Fornarini, G; Valcamonico, F; Zustovich, F; Massari, F; Zanardi, E; Roma, A; Zattoni, F; Zagonel, V
Radiofrequency ablation of liver malignancies: MRI for evaluation of response
2004-01-01 Aliberti, C; Soriani, M; Tilli, M; Benea, G; De Giorgi, U; Fiorentini, G
Circulating tumor cells in newly diagnosed inflammatory breast cancer
2015-01-01 Mego, M; Giordano, A; De Giorgi, U; Masuda, H; Hsu, L; Giuliano, M; Fouad, Tm; Dawood, S; Ueno, Nt; Valero, V; Andreopoulou, E; Alvarez, Rh; Woodward, Wa; Hortobagyi, Gn; Cristofanilli, M; Reuben, Jm
Methylation pattern analysis in prostate cancer tissue: Identification of biomarkers using an MS-MLPA approach
2016-01-01 Gurioli, G; Salvi, S; Martignano, F; Foca, F; Gunelli, R; Costantini, M; Cicchetti, G; De Giorgi, U; Sbarba, Pd; Calistri, D; Casadio, V
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer
2018-01-01 Malaspina, Simona; De Giorgi, Ugo; Kemppainen, Jukka; Del Sole, Angelo; Paganelli, Giovanni
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)
2016-01-01 Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb.
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
2019-01-01 Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; Scarpi, E; Castro, E; Marin-Aguilera, M; Lolli, C; Schepisi, G; Maugeri, A; Wingate, A; Farolfi, A; Casadio, V; Medina, A; Puente, J; Vidal, Mjm; Morales-Barrera, R; Villa-Guzmán, Jc; Hernando, S; Rodriguez-Vida, A; González-Del-Alba, A; Mellado, B; Gonzalez-Billalabeitia, E; Olmos, D; Attard, G; De Giorgi, U
Salvage high-dose chemotherapy in patients with germ cell tumors: an Italian experience with 84 patients
2002-01-01 Rosti, G; De Giorgi, U; Salvioni, R; Papiani, G; Sebastiani, L; Argnani, M; Monti, G; Ferrante, P; Pizzocaro, G; Marangolo, M.
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study
2014-01-01 Escudier, B; Porta, C; Bono, P; Powles, T; Eisen, T; Sternberg, Cn; Gschwend, Je; De Giorgi, U; Parikh, O; Hawkins, R; Sevin, E; Négrier, S; Khan, S; Diaz, J; Redhu, S; Mehmud, F; Cella, D.
Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies
2014-01-01 Conteduca, V; Aieta, M; Amadori, D; De Giorgi, U
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function
2015-01-01 De Giorgi, U; Yuan, J; Moroni, M; Veronese, S; Sartore-Bianchi, A; Broggini, M; Rosti, G; Strebhardt, K; Ruffini, Pa
Hyperthermia and hypoxia: new developments in anticancer chemotherapy
2001-01-01 Zaffaroni, N; Fiorentini, G; De Giorgi, U
PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer
2015-01-01 Burgio, Sl; Conteduca, V; Rudnas, B; Carrozza, F; Campadelli, E; Bianchi, E; Fabbri, P; Montanari, M; Carretta, E; Menna, C; De Giorgi, U
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
2010-01-01 International Prognostic Factors Study, Group; Lorch, A; Beyer, J; Bascoul-Mollevi, C; Kramar, A; Einhorn, Lh; Necchi, A; Massard, C; De Giorgi, U; Fléchon, A; Margolin, Ka; Lotz, Jp; Germa Lluch, Jr; Powles, T; Kollmannsberger, Ck.
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience
2005-01-01 De Giorgi, U; Demirer, T; Wandt, H; Taverna, C; Siegert, W; Bornhauser, M; Kozak, T; Papiani, G; Ballardini, M; Rosti, G
Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results
2017-01-01 Matteucci, F; Mezzenga, E; Caroli, P; Di Iorio, V; Sarnelli, A; Celli, M; Fantini, L; Moretti, A; Galassi, R; De Giorgi, U; Paganelli, G
Immunotherapy for prostate cancer: where we are headed
2017-01-01 Schepisi, G; Farolfi, A; Conteduca, V; Martignano, F; De Lisi, D; Ravaglia, G; Rossi, L; Menna, C; Bellia, Sr; Barone, D; Gunelli, R; De Giorgi, U
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer
2012-01-01 De Giorgi, U; Mego, M; Scarpi, E; Giuliano, M; Giordano, A; Reuben, Jm; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1 | 1-gen-2016 | Smith, M; De Bono, J; Sternberg, C; Le Moulec, S; Oudard, S; De Giorgi, U; Krainer, M; Bergman, A; Hoelzer, W; De Wit, R; Bögemann, M; Saad, F; Cruciani, G; Thiery-Vuillemin, A; Feyerabend, S; Miller, K; Houédé, N; Hussain, S; Lam, E; Polikoff, J; Stenzl, A; Mainwaring, P; Ramies, D; Hessel, C; Weitzman, A; Fizazi, K. | |
| Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer | 1-gen-2016 | Passardi, A; Scarpi, E; Cavanna, L; Dall'Agata, M; Tassinari, D; Leo, S; Bernardini, I; Gelsomino, F; Tamberi, S; Brandes, Aa; Tenti, E; Vespignani, R; Frassineti, Gl; Amadori, D; De Giorgi, U | |
| Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey | 1-gen-2016 | Diminutto, A; Basso, U; Maruzzo, M; Morelli, F; De Giorgi, U; Perin, A; Fraccon, Ap; Lo Re, G; Rizzi, A; Sava, T; Fornarini, G; Valcamonico, F; Zustovich, F; Massari, F; Zanardi, E; Roma, A; Zattoni, F; Zagonel, V | |
| Radiofrequency ablation of liver malignancies: MRI for evaluation of response | 1-gen-2004 | Aliberti, C; Soriani, M; Tilli, M; Benea, G; De Giorgi, U; Fiorentini, G | |
| Circulating tumor cells in newly diagnosed inflammatory breast cancer | 1-gen-2015 | Mego, M; Giordano, A; De Giorgi, U; Masuda, H; Hsu, L; Giuliano, M; Fouad, Tm; Dawood, S; Ueno, Nt; Valero, V; Andreopoulou, E; Alvarez, Rh; Woodward, Wa; Hortobagyi, Gn; Cristofanilli, M; Reuben, Jm | |
| Methylation pattern analysis in prostate cancer tissue: Identification of biomarkers using an MS-MLPA approach | 1-gen-2016 | Gurioli, G; Salvi, S; Martignano, F; Foca, F; Gunelli, R; Costantini, M; Cicchetti, G; De Giorgi, U; Sbarba, Pd; Calistri, D; Casadio, V | |
| 68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer | 1-gen-2018 | Malaspina, Simona; De Giorgi, Ugo; Kemppainen, Jukka; Del Sole, Angelo; Paganelli, Giovanni | |
| Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) | 1-gen-2016 | Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb. | |
| Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer | 1-gen-2019 | Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; Scarpi, E; Castro, E; Marin-Aguilera, M; Lolli, C; Schepisi, G; Maugeri, A; Wingate, A; Farolfi, A; Casadio, V; Medina, A; Puente, J; Vidal, Mjm; Morales-Barrera, R; Villa-Guzmán, Jc; Hernando, S; Rodriguez-Vida, A; González-Del-Alba, A; Mellado, B; Gonzalez-Billalabeitia, E; Olmos, D; Attard, G; De Giorgi, U | |
| Salvage high-dose chemotherapy in patients with germ cell tumors: an Italian experience with 84 patients | 1-gen-2002 | Rosti, G; De Giorgi, U; Salvioni, R; Papiani, G; Sebastiani, L; Argnani, M; Monti, G; Ferrante, P; Pizzocaro, G; Marangolo, M. | |
| Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study | 1-gen-2014 | Escudier, B; Porta, C; Bono, P; Powles, T; Eisen, T; Sternberg, Cn; Gschwend, Je; De Giorgi, U; Parikh, O; Hawkins, R; Sevin, E; Négrier, S; Khan, S; Diaz, J; Redhu, S; Mehmud, F; Cella, D. | |
| Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies | 1-gen-2014 | Conteduca, V; Aieta, M; Amadori, D; De Giorgi, U | |
| Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function | 1-gen-2015 | De Giorgi, U; Yuan, J; Moroni, M; Veronese, S; Sartore-Bianchi, A; Broggini, M; Rosti, G; Strebhardt, K; Ruffini, Pa | |
| Hyperthermia and hypoxia: new developments in anticancer chemotherapy | 1-gen-2001 | Zaffaroni, N; Fiorentini, G; De Giorgi, U | |
| PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer | 1-gen-2015 | Burgio, Sl; Conteduca, V; Rudnas, B; Carrozza, F; Campadelli, E; Bianchi, E; Fabbri, P; Montanari, M; Carretta, E; Menna, C; De Giorgi, U | |
| Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. | 1-gen-2010 | International Prognostic Factors Study, Group; Lorch, A; Beyer, J; Bascoul-Mollevi, C; Kramar, A; Einhorn, Lh; Necchi, A; Massard, C; De Giorgi, U; Fléchon, A; Margolin, Ka; Lotz, Jp; Germa Lluch, Jr; Powles, T; Kollmannsberger, Ck. | |
| Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience | 1-gen-2005 | De Giorgi, U; Demirer, T; Wandt, H; Taverna, C; Siegert, W; Bornhauser, M; Kozak, T; Papiani, G; Ballardini, M; Rosti, G | |
| Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results | 1-gen-2017 | Matteucci, F; Mezzenga, E; Caroli, P; Di Iorio, V; Sarnelli, A; Celli, M; Fantini, L; Moretti, A; Galassi, R; De Giorgi, U; Paganelli, G | |
| Immunotherapy for prostate cancer: where we are headed | 1-gen-2017 | Schepisi, G; Farolfi, A; Conteduca, V; Martignano, F; De Lisi, D; Ravaglia, G; Rossi, L; Menna, C; Bellia, Sr; Barone, D; Gunelli, R; De Giorgi, U | |
| Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer | 1-gen-2012 | De Giorgi, U; Mego, M; Scarpi, E; Giuliano, M; Giordano, A; Reuben, Jm; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 03 Articolo su Rivista38605
Data di pubblicazione
- In corso di stampa43
- 2020 - 202710433
- 2010 - 201913552
- 2000 - 20098692
- 1990 - 19993962
- 1980 - 19891442
- 1970 - 1979447
- 1961 - 196934
Editore
- Elsevier BV:PO Box 211, 1000 AE A...454
- American Institute of Physics:2 H...272
- Giuffre Editore Spa:via Busto Ars...128
- Elsevier Science Limited:Oxford F...99
- Congedo Editore Luogo pubbl. Gal...72
- IOP Publishing Limited:Dirac Hous...71
- Springer Verlag Germany:Tiergarte...71
- Kluwer Academic Publishers:Journa...54
- IEEE / Institute of Electrical an...47
- Societa Editrice il Mulino Spa:St...43
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS481
- THE EUROPEAN PHYSICAL JOURNAL. C,...393
- PHYSICS LETTERS. SECTION B392
- PHYSICAL REVIEW LETTERS211
- APPLIED PHYSICS LETTERS186
- NUCLEAR INSTRUMENTS AND METHODS I...185
- THE ASTROPHYSICAL JOURNAL180
- PHYSICAL REVIEW D, PARTICLES, FIE...156
- PHYSICAL REVIEW D148
- ITINERARI DI RICERCA STORICA140
Keyword
- ATLAS1158
- LHC1151
- High Energy Physics1130
- Humans376
- Mediterranean Sea185
- Italy177
- Female144
- Animals143
- Male127
- Hadron-Hadron Scattering122
Lingua
- eng25985
- ita9002
- fre415
- spa191
- ger146
- por94
- lat51
- grc47
- rus43
- chi13
Accesso al fulltext
- no fulltext32279
- open4081
- restricted1185
- reserved1012
- partially open32
- mixed10
- embargoed6